DrugPatentWatch Database Preview
Drugs in Development Information for Tocotrienol
» See Plans and Pricing
What is the drug development status for Tocotrienol?
Tocotrienol is an investigational drug.
There have been 22 clinical trials for Tocotrienol.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2016.
The most common disease conditions in clinical trials are Ovarian Neoplasms, Pancreatic Neoplasms, and Breast Neoplasms. The leading clinical trial sponsors are Vejle Hospital, H. Lee Moffitt Cancer Center and Research Institute, and Texas Tech University Health Sciences Center.
There are thirty-one US patents protecting this investigational drug and two hundred international patents.
Summary for Tocotrienol
US Patents | 31 |
International Patents | 200 |
US Patent Applications | 48 |
WIPO Patent Applications | 22 |
Japanese Patent Applications | 0 |
Clinical Trial Progress | Phase 2 (2016-01-01) |
Vendors | 2 |
Recent Clinical Trials for Tocotrienol
Title | Sponsor | Phase |
---|---|---|
A Randomized, Double-Blind, Placebo-Controlled Study, to Assess the Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL) | Hovid Berhad | Phase 2 |
A Randomized, Double-Blind, Placebo-Controlled Study, to Assess the Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL) | Monash University Malaysia | Phase 2 |
A Randomized, Double-Blind, Placebo-Controlled Study, to Assess the Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL) | Yuen Kah Hay | Phase 2 |
Clinical Trial Summary for Tocotrienol
Top disease conditions for Tocotrienol
Top clinical trial sponsors for Tocotrienol
US Patents for Tocotrienol
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
Tocotrienol | Start Trial | Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders | Bristol-Myers Squibb Company (New York, NY) | Start Trial |
Tocotrienol | Start Trial | Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders | Bristol-Myers Squibb Company (New York, NY) | Start Trial |
Tocotrienol | Start Trial | Antioxidant compositions for coating substrates, substrates coated with the same and methods for inhibiting the oxidation of such compositions applied to a substrate | PPG Industries, Inc. (Pittsburgh, PA) | Start Trial |
Tocotrienol | Start Trial | Substrates coated with antioxidant compositions and method for inhibiting the oxidation of such compositions applied to a substrate | PPG Industries, Inc. (Pittsburgh, PA) | Start Trial |
Tocotrienol | Start Trial | Stabilizer in solid form for organic polymers | Great Lakes Chemical (Europe) GmbH (Fraunfeld, CH) | Start Trial |
Tocotrienol | Start Trial | Tocotrienols and tocotrienol-like compounds and methods for their use | Lipogenics, Inc. (Phoenix, AR) | Start Trial |
Tocotrienol | Start Trial | Tocotrienols and tocotrienol-like compounds and methods for their use | Lipogenics, Inc. (Phoenix, AZ) | Start Trial |
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Tocotrienol
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
Tocotrienol | Canada | CA2026713 | 2009-10-04 | Start Trial |
Tocotrienol | European Patent Office | EP0421419 | 2009-10-04 | Start Trial |
Tocotrienol | Hungary | HU207442 | 2009-10-04 | Start Trial |
Tocotrienol | Hungary | HU906297 | 2009-10-04 | Start Trial |
Tocotrienol | Hungary | HUT54887 | 2009-10-04 | Start Trial |
Tocotrienol | Israel | IL95857 | 2009-10-04 | Start Trial |
Tocotrienol | Japan | JPH03246222 | 2009-10-04 | Start Trial |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |